Director/PDMR Shareholding
![](https://tracker.live.rns-distribution.com/track.live-rns/5277440_d9353a075fe0b610698e373da828b7e4.png)
23 July 2024
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Director / PDMR Dealing
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that Neil Campbell, Non-Executive Director, has gifted a total of 71,428 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") to his children, Oliver Campbell and Edward Campbell, for nil consideration. This is in accordance with Neil Campbell's intention, as stated in the Company's Result of Placing and Subscription announcement on 26 June 2024.
The 71,428 Ordinary Shares are being gifted equally, with 35,714 Ordinary Shares to Oliver Campbell and 35,714 Ordinary Shares to Edward Campbell. Oliver and Edward Campbell are both PCAs of Neil Campbell.
Following the transfer, Neil Campbell holds 4,416,646 Ordinary Shares representing approximately 4.93% of the Company's issued share capital, Oliver Campbell holds 43,330 Ordinary Shares representing approximately 0.05% of the Company's issued share capital, and Edward Campbell holds 35,714 Ordinary Shares representing approximately 0.04% of the Company's issued share capital.
The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail on the shares gifted.
For further information:
|
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Neil Campbell | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PDMR - Non-Executive Director | ||||||
b) | Initial notification /Amendment | Initial | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Inspiration Healthcare Group plc
| ||||||
b) | LEI | 213800GKFT3ENAPMDL15
| ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105 | ||||||
b) | Nature of the transaction | Gift of shares to his children | ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information - Aggregated volume - Price |
| ||||||
e) | Date of the transaction | 23 July 2024 | ||||||
f) | Place of the transaction | Outside of a trading venue |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Oliver Campbell | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PCA of Neil Campbell, Non-Executive Director | ||||||
b) | Initial notification /Amendment | Initial | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Inspiration Healthcare Group plc
| ||||||
b) | LEI | 213800GKFT3ENAPMDL15
| ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105 | ||||||
b) | Nature of the transaction | Receipt of shares from Neil Campbell | ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information - Aggregated volume - Price |
| ||||||
e) | Date of the transaction | 23 July 2024 | ||||||
f) | Place of the transaction | Outside of a trading venue |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Edward Campbell | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PCA of Neil Campbell, Non-Executive Director | ||||||
b) | Initial notification /Amendment | Initial | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Inspiration Healthcare Group plc
| ||||||
b) | LEI | 213800GKFT3ENAPMDL15
| ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105 | ||||||
b) | Nature of the transaction | Receipt of shares from Neil Campbell | ||||||
c)
| Price(s) and volume(s)
|
| ||||||
d)
| Aggregated information - Aggregated volume - Price |
| ||||||
e) | Date of the transaction | 23 July 2024 | ||||||
f) | Place of the transaction | Outside of a trading venue |
About Inspiration Healthcare Group plc
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.